Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 14.60 billion as of April 29, 2025. Its market cap has increased by 83.35% in one year.

Market Cap

14.60B

Enterprise Value

15.87B

Revenue

34.68M

Ranking

n/a

PE Ratio

n/a

Stock Price

62.50

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 14.60B, a decrease of -12.97%. That is a compound annual growth rate of -1.42%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2025	14.91B	39.34%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.02B
Caliway Biopharmaceuticals	98.64B
Bora Pharmaceuticals Co., LTD.	70.86B
Lotus Pharmaceutical	57.54B
Oneness Biotech	29.69B
Polaris Group	28.38B
Lumosa Therapeutics	26.77B
Pegavision	25.55B

Market Cap Rankings